Dr. Shishir Seth

MBBS, MD, DM (Clinical Hematology)

Senior Consultant – Department of Adult Hemato-Oncology & Bone Marrow Transplant

20+ Years of Experience

Delhi NCR

Dr. Shishir Seth is a highly distinguished and elite clinical hematologist specializing in Adult Bone Marrow Transplantation (BMT) and Hemato-Oncology. After acquiring his foundational medical degrees, he completed his DM in Clinical Hematology from Mumbai and went on to complete a highly coveted Clinical Fellowship in Leukemia and Blood & Marrow Transplantation at the world-renowned Division of Hematology, Vancouver General Hospital, Canada. With over two decades of comprehensive experience, Dr. Seth is widely acclaimed for his masterclass proficiency in managing volatile adult blood cancers and structural bone marrow failures. Known for his meticulous clinical approach and compassionate, reassuring care, he guides patients safely through the complex phases of intensive pre-transplant conditioning and post-transplant recovery. He remains at the cutting edge of cellular therapies, serving as a principal investigator for advanced international clinical trials.

Adult Bone Marrow Transplantation: Meticulous execution of Autologous and Allogeneic transplants, including high-risk HLA-mismatched and Haploidentical protocols.
Hematological Malignancies: Advanced therapeutic protocols and targeted induction therapies for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Lymphomas, and Multiple Myeloma.
Bone Marrow Failure Syndromes: Definitive curative management of Severe Aplastic Anemia, Myelodysplastic Syndromes (MDS), and severe hemoglobinopathies.
Benign Hematology: Comprehensive care for complex, treatment-resistant bleeding disorders, coagulation anomalies, and refractory anemias.

Successfully performed over 200 high-complexity hematopoietic stem cell transplants, with a substantial portion comprising challenging allogeneic and antigen-mismatch cases.
Spearheaded more than 300 successful, intensive induction therapy cycles for critical, newly diagnosed acute leukemia patients.
Served as the Principal Investigator for pioneering clinical research evaluating next-generation targeted therapies, including Bendamustine and Rituximab combinations.

Life Member of the prestigious Indian Society of Hematology and Transfusion Medicine (ISHTM).
Active international member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).
Widely published across globally indexed, peer-reviewed medical journals detailing advanced outcomes in leukemia and transplant biology.

Dr. Shishir Seth

More Hematology Specialists

Dr. Rahul Bhargava

Dr. Arun Singh Danewa

Dr. Gaurav Dixit